Helen Heslop, MD Elected to National Academy of Medicine
Congratulations, Dr. Heslop!
Dr. Helen Elisabeth Heslop has received the prestigious honor of being elected to the National Academy of Medicine. This honor recognizes outstanding professional achievement and commitment to service in the health and medicine fields, and Dr. Heslop is the epitome of both.
According to the National Academy of Medicine website, Dr. Heslop was elected, βfor pioneering work in complex biological therapies, leadership in clinical immunotherapy, and for being the first to employ donor and banked cytotoxic T cells to treat lethal virus-associated malignancies and infections in pivotal trials.β
Not only has Dr. Heslop achieved such remarkable successes for the field of cellular therapy, but she has done so as a servant leader. She dedicates much of her time volunteering for important initiatives to share her knowledge and raise the quality and effectiveness of cellular therapies for health care institutions and patients around the world. Dr. Heslop has tirelessly served FACT as a past President, current chair of the FACT Immune Effector Cell Task Force, and as a co-chair and member of numerous FACT committees such as the Standards and Accreditation Committees. In these positions, she has led FACT-accredited programs, inspectors, and our many stakeholders through transformational changes in the field, embodying the spirit of collaboration in cellular therapy.
Please join us in congratulating and celebrating Dr. Heslop!
